Anders Martin-Löf
Finanzdirektor/CFO bei BIOARCTIC AB
Vermögen: 15 197 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Lars Gunnar Lannfelt | M | 75 | 21 Jahre | |
| Pär Lars Gellerfors | M | 77 | 21 Jahre | |
| Sofia Heigis | F | 44 | 4 Jahre | |
| Thoas Michael Fioretos | M | 66 | 15 Jahre | |
| Eugen Steiner | M | 70 | 7 Jahre | |
| Göran Forsberg | M | 61 | 10 Jahre | |
| Karolina Vilval | F | 45 |
Oncopeptides Incentive AB
| 3 Jahre |
| Patricia Delaite | M | 61 | 7 Jahre | |
| Flavia Borellini | M | 65 | 4 Jahre | |
| Karin Leandersson | F | 52 | 8 Jahre | |
| Bengt Håkan Englund | M | 72 | 4 Jahre | |
| Gunilla Christina Osswald | M | 63 | 11 Jahre | |
| Jan Mattsson | M | 64 | 7 Jahre | |
| Jennifer Jackson | M | 71 | 6 Jahre | |
| Joachim Feldwisch | M | - |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Lennart Rolf Ivar Verner | M | 77 | 14 Jahre | |
| Martin Duvall | M | 62 |
Oncopeptides Incentive AB
| 2 Jahre |
| Oskar Bosson | M | 48 | 4 Jahre | |
| Åke Mikael Smedeby | M | 56 | 6 Jahre | |
| Gunnar Magnus Modee Persson | M | 64 | 8 Jahre | |
| Stig Anders Lindberg | M | 52 |
Oncopeptides Incentive AB
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Karin Nord | M | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 Jahre |
| Carl Erik Mathias Uhlén | M | 70 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 Jahre |
| Charlotta Ljungqvist | M | 63 | 3 Jahre | |
| Damian Marron | M | 62 | 3 Jahre | |
| Magnus Nilsson | M | 68 | 3 Jahre | |
| Anna-Kaija Grönblad | F | 56 | 3 Jahre | |
| Camilla Soenderby | F | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Lotta Larsson | F | - | 14 Jahre | |
| Gunilla Andersson | F | 63 | 5 Jahre | |
| David Liberg | M | 55 | 9 Jahre | |
| Johanna Fälting | M | 52 | 12 Jahre | |
| Patrik Renblad | M | 54 | 1 Jahre | |
| Lars Thorsson | M | 63 | 9 Jahre | |
| Liselotte Larsson | M | 61 | 10 Jahre | |
| Lars Jordeby | M | 59 | 10 Jahre | |
| Alan Hulme | M | - |
Oncopeptides Incentive AB
| - |
| David Bejker | M | 49 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 6 Jahre |
| Robert Forbes Burns | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Dominique Tersago | M | 62 | 2 Jahre | |
| Tomas Odergren | M | 65 | 5 Jahre | |
| Peter Kemlin | M | 50 | 12 Jahre | |
| Cecilia Marie Edström | F | 58 | 1 Jahre | |
| Jose F. Suarez | M | 54 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Nedjad Losic | M | 54 | 3 Jahre | |
| Christer Möller | M | 65 | 18 Jahre | |
| J. Kenneth Charles Knowles | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 | 7 Jahre | |
| Rolf Gulliksen | M | 65 | 3 Jahre | |
| Peter Thysell | M | 54 | 6 Jahre | |
| Victoria Sörving | F | 38 | - | |
| Johan Georg Harmenberg | M | 70 | 7 Jahre | |
| Klaas Bakker | M | 42 | - | |
| Roger Belusa | M | - | - | |
| Susanne Lagerlund | F | 56 | 3 Jahre | |
| Peter Juul Madsen | M | - | 2 Jahre | |
| Ignacio Garcia-Ribas | M | - | 2 Jahre | |
| Karin Eklund Vanderpol | F | 51 | 2 Jahre | |
| Linda Holmström | F | - | - | |
| Corinne Savill | M | 64 | - | |
| Christian Jacques | M | 68 | 2 Jahre | |
| Elisabeth Augustsson | F | 59 | 5 Jahre | |
| Bengt Jöndell | M | 64 | 6 Jahre | |
| Annika Muskantor | F | 58 | 2 Jahre | |
| Karin Birgitta Margareta Ståhl | F | 53 | 2 Jahre | |
| Claus Asbjørn Andersson | M | 56 | 8 Jahre | |
| Rein Piir | M | 66 | 4 Jahre | |
| Han Jing Xie | M | 54 | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Schweden | 68 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Anders Martin-Löf
- Persönliches Netzwerk
